Latest radiation therapy Stories

ViewRay Appoints Chris A. Raanes President and CEO

2013-02-04 08:25:40

CLEVELAND, Feb. 4, 2013 /PRNewswire/ -- ViewRay(TM) Incorporated, a privately held medical device company, today announced that its board of directors has appointed industry veteran Chris A. Raanes as president and CEO, effective immediately. Raanes joins ViewRay from Accuray Incorporated, where he served as executive vice president and chief operating officer. At ViewRay, he will be charged with driving the worldwide commercial growth of the ViewRay system, which provides a unique...

Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference

2013-01-31 08:30:23

MADISON, Wis., Jan. 31, 2013 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that an oral presentation on research conducted by Novelos and its collaborators is being made by Dr. Christopher Pazoles at the EMIT: Targeted Radiotherapy international conference taking place January 29 to 31, in Washington, D.C. This presentation by invitation from EMIT describes the...

El Portal Comprehensive Cancer Center Moves to Completely New, State of the Art Facility

2013-01-29 23:03:21

One of the California's most modern Cancer Centers, El Portal Comprehensive Cancer is moving to a much-anticipated new location in Merced. Their new office features a plethora of innovative, highly-effective treatments including stereotactic radiotherapy and high dose rate brachytherapy. Merced, California (PRWEB) January 29, 2013 El Portal Comprehensive Cancer is moving to a much-anticipated new location in Merced that will better enable them to help members of the community who are...

Landauer, Inc. Sets Date And Time For Announcement Of Fiscal First Quarter 2013 Results

2013-01-29 16:21:17

GLENWOOD, Ill., Jan. 29, 2013 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, will release financial results for the fiscal first quarter 2013 after the market close on Monday, February 11, 2013. The Company will host a conference call for investors on Tuesday, February 12, 2013, at 9:00 a.m. Central Time (10 a.m....

Premier Cancer Centers Dallas announces addition of the Accuray TomoTherapy® H(TM) Series

2013-01-29 08:30:05

DALLAS, Jan. 29, 2013 /PRNewswire/ -- Premier Cancer Centers Dallas, opening spring of 2013, will offer both Stereotactic Radiosurgery (SRS/SBRT) and Intensity Modulated Radiation Therapy (IMRT) in one location to meet the needs of cancer patients everywhere. With these technologies, Cancer Has Met Its Match! (Logo: http://photos.prnewswire.com/prnh/20130129/DA49719LOGO) Premier Cancer Centers Dallas is bringing the first TomoTherapy H Series to Texas. The H Series was created...

FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)

2013-01-29 08:29:39

PRINCETON, N.J., Jan. 29, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today that its OrbeShield(TM) (oral beclomethasone 17,21-dipropionate or oral BDP) development program for the treatment of GI ARS has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA). Soligenix has also previously received Orphan Drug designation from the FDA for oral BDP for the prevention...

Less Invasive Treatment Is Linked To Improved Survival In Early Stage Breast Cancer

2013-01-28 15:50:53

Patients with early stage breast cancer who were treated with lumpectomy plus radiation may have a better chance of survival compared with those who underwent mastectomy, according to Duke Medicine research. The study, which appears online Jan. 28, 2013, in the journal Cancer, raises new questions as to the comparative effectiveness of breast-conserving therapies such as lumpectomy, where only the tumor and surrounding tissue is surgically removed. “Our findings are observational but...

Study Finds Qigong Improves Quality Of Life For Breast Cancer Patients

2013-01-28 14:06:57

Results underscore growing benefits of mind-body practices in oncology Researchers from The University of Texas MD Anderson Cancer Center have found qigong, an ancient mind-body practice, reduces depressive symptoms and improves quality of life in women undergoing radiotherapy for breast cancer. The study, published in the journal Cancer, is the first to examine qigong in patients actively receiving radiation therapy and include a follow-up period to assess benefits over time. Even...

Voices Against Brain Cancer Responds to the Use of More Focused Radiation to Treat Brain Tumors

2013-01-26 23:02:38

Voices Against Brain Cancer responds to an article that reports on new research suggesting that a more focused form of radiation treatment can be more effective for treating brain tumors. New York, NY (PRWEB) January 26, 2013 On January 26, Voices Against Brain Cancer (VABC) responds to a recent article published by Health.com regarding a new form of radiation treatment that has the potential to be a more effective tool in the fight against brain cancer. New research suggests that the use...

Elekta and Philips Gain MD Anderson Cancer Center as Collaborator in Research Consortium on MRI-Guided Radiation Therapy

2013-01-24 08:32:18

ATLANTA, Jan. 24, 2013 /PRNewswire/ -- Elekta (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) announced today that The University of Texas MD Anderson Cancer Center (Houston, Texas) has signed an agreement to join a research group to advance the development of an innovative image-guided treatment technology for cancer care. The technology merges radiation therapy and magnetic resonance imaging (MRI) technology in a single system. MD Anderson is the second member of...